Search

Robert S. Landsman

Examiner (ID: 14280, Phone: (571)272-0888 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1647, 1646
Total Applications
2029
Issued Applications
1242
Pending Applications
272
Abandoned Applications
566

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6234903 [patent_doc_number] => 20100266607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TRACT' [patent_app_type] => utility [patent_app_number] => 12/753438 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18508 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266607.pdf [firstpage_image] =>[orig_patent_app_number] => 12753438 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/753438
Methods of using anti-TNF antibodies for treating radiation damage to the digestive tract Apr 1, 2010 Issued
Array ( [id] => 9944209 [patent_doc_number] => 08993509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity' [patent_app_type] => utility [patent_app_number] => 13/262094 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27466 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262094 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/262094
Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity Mar 30, 2010 Issued
Array ( [id] => 7743210 [patent_doc_number] => 20120021440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'METHODS FOR TESTING LIGAND BINDING TO G PROTEIN-COUPLED RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/262129 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11258 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021440.pdf [firstpage_image] =>[orig_patent_app_number] => 13262129 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/262129
METHODS FOR TESTING LIGAND BINDING TO G PROTEIN-COUPLED RECEPTORS Mar 25, 2010 Abandoned
Array ( [id] => 8158407 [patent_doc_number] => 20120100130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'Novel Receptor Hetero-Dimers/-Oligomers' [patent_app_type] => utility [patent_app_number] => 13/260530 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21571 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100130.pdf [firstpage_image] =>[orig_patent_app_number] => 13260530 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/260530
Novel Receptor Hetero-Dimers/-Oligomers Mar 25, 2010 Abandoned
Array ( [id] => 9648802 [patent_doc_number] => 08802815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression' [patent_app_type] => utility [patent_app_number] => 13/257332 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 6585 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257332 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/257332
Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression Mar 17, 2010 Issued
Array ( [id] => 6383728 [patent_doc_number] => 20100317098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer' [patent_app_type] => utility [patent_app_number] => 12/724169 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22124 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317098.pdf [firstpage_image] =>[orig_patent_app_number] => 12724169 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/724169
Nucleic acid molecules encoding soluble frizzled (FZD) receptors Mar 14, 2010 Issued
Array ( [id] => 8361141 [patent_doc_number] => 20120216303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/723163 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9343 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12723163 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/723163
NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS Mar 11, 2010 Abandoned
Array ( [id] => 7988321 [patent_doc_number] => 08076456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/721002 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 16310 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076456.pdf [firstpage_image] =>[orig_patent_app_number] => 12721002 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/721002
Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof Mar 9, 2010 Issued
Array ( [id] => 6289886 [patent_doc_number] => 20100158908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Stable Polypeptide Formulations' [patent_app_type] => utility [patent_app_number] => 12/718898 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24256 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158908.pdf [firstpage_image] =>[orig_patent_app_number] => 12718898 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/718898
Stable polypeptide formulations Mar 4, 2010 Issued
Array ( [id] => 8305672 [patent_doc_number] => 08227199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Methods for identifying immunobinders of cell-surface antigens' [patent_app_type] => utility [patent_app_number] => 12/710579 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 15984 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12710579 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/710579
Methods for identifying immunobinders of cell-surface antigens Feb 22, 2010 Issued
Array ( [id] => 6434680 [patent_doc_number] => 20100152427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'NUCLEIC ACID ENCODING A NOVEL DP RECEPTOR PROTEIN AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/710556 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29090 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152427.pdf [firstpage_image] =>[orig_patent_app_number] => 12710556 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/710556
NUCLEIC ACID ENCODING A NOVEL DP RECEPTOR PROTEIN AND METHODS OF USE THEREOF Feb 22, 2010 Abandoned
Array ( [id] => 4639547 [patent_doc_number] => 08017574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => 'Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues' [patent_app_type] => utility [patent_app_number] => 12/700443 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 47762 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017574.pdf [firstpage_image] =>[orig_patent_app_number] => 12700443 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/700443
Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues Feb 3, 2010 Issued
Array ( [id] => 7522918 [patent_doc_number] => 08026074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => 'Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual' [patent_app_type] => utility [patent_app_number] => 12/700394 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 47771 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026074.pdf [firstpage_image] =>[orig_patent_app_number] => 12700394 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/700394
Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual Feb 3, 2010 Issued
Array ( [id] => 6518836 [patent_doc_number] => 20100203037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHODS OF USING GPR119 TO IDENTIFY COMPOUNDS USEFUL FOR INCREASING BONE MASS IN AN INDIVIDUAL' [patent_app_type] => utility [patent_app_number] => 12/700423 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 47673 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203037.pdf [firstpage_image] =>[orig_patent_app_number] => 12700423 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/700423
Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues Feb 3, 2010 Issued
Array ( [id] => 4629560 [patent_doc_number] => 08008451 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Antibodies to TNF (tumor necrosis factor) receptor family members' [patent_app_type] => utility [patent_app_number] => 12/697676 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8640 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008451.pdf [firstpage_image] =>[orig_patent_app_number] => 12697676 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/697676
Antibodies to TNF (tumor necrosis factor) receptor family members Jan 31, 2010 Issued
Array ( [id] => 4493651 [patent_doc_number] => 07947271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents' [patent_app_type] => utility [patent_app_number] => 12/694092 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 22388 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947271.pdf [firstpage_image] =>[orig_patent_app_number] => 12694092 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/694092
Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents Jan 25, 2010 Issued
Array ( [id] => 7766192 [patent_doc_number] => 20120034235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker' [patent_app_type] => utility [patent_app_number] => 13/145773 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5670 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034235.pdf [firstpage_image] =>[orig_patent_app_number] => 13145773 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/145773
Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker Jan 21, 2010 Abandoned
Array ( [id] => 6228894 [patent_doc_number] => 20100183632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Antibody Therapy For Modulating Function Of Intestinal Receptors' [patent_app_type] => utility [patent_app_number] => 12/687660 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11413 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183632.pdf [firstpage_image] =>[orig_patent_app_number] => 12687660 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/687660
Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity Jan 13, 2010 Issued
Array ( [id] => 8522235 [patent_doc_number] => 20120321643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/509235 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5021 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509235 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/509235
Anti-epidermal growth factor receptor antibodies and uses thereof Dec 29, 2009 Issued
Array ( [id] => 6411324 [patent_doc_number] => 20100166658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'MONKEY HOMOLOG OF HUMAN ONCOSTATIN M' [patent_app_type] => utility [patent_app_number] => 12/648430 [patent_app_country] => US [patent_app_date] => 2009-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6753 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166658.pdf [firstpage_image] =>[orig_patent_app_number] => 12648430 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/648430
Monkey homolog of human oncostatin M and methods of use thereof Dec 28, 2009 Issued
Menu